Naxions closes multi-million-dollar financing round, provides intelligent medical marketing solution

Beijing-based Naxions announced the completion of a financing round of tens of millions of dollars, led by Zhichun Capital, Matrix Partners China and Morningside Venture Capital, with participation from existing investors CCV, Volcanics Venture and angel round investor Frees Fund.

Beijing-based Naxions announced the completion of a financing round of tens of millions of dollars, led by Zhichun Capital, Matrix Partners China and Morningside Venture Capital, with participation from existing investors CCV, Volcanics Venture and angel round investor Frees Fund.

Ruan Wei, founder and CEO of Naxions, said that proceeds from this round of financing will mainly be used for business expansion, technological investment and product optimization.

Founded in 2014, Naxions is an AI-based technology company providing digital marketing solutions for drug manufacturing enterprises through natural language processing (NLP), big data analysis, and neural network algorithm, to integrate regional medical data.

Naxions creates a medical knowledge map and puts the doctor in the central place, covering radiation medicine, diagnosis, treatment, materials, and surgeries, to pass the information of new drugs to doctors efficiently, enabling doctors at the grass-roots level to obtain the same professional knowledge.

Naxions currently connects 20 leading pharmaceutical companies with about 45,000 doctors in China. It serves dozens of world top 500 pharmaceutical companies including Pfizer, Janssen, and Bayer.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/04/naxions-closes-multi-million-dollar-financing-round-provides-intelligent-medical-marketing-solution/.

Leave a Reply

Please Login to Comment